Press Release Vector Science and Therapeutics Corp. Enters Into an Investor Relations Agreement and Grants Options 12 hours ago
Press Release Vector Science & Therapeutics (TSXV: PAIN) Begins Peptide Production as First Suite at LyoGenesis Manufacturing Comes Online Aug 24
Press Release Vector Science and Therapeutics Corp. (TSXV: PAIN) Files Provisional Patent Application on Integrated Platform for Orthopedic Tissue Regeneration Using Peptides Aug 20
Press Release Vector Science and Therapeutics Corp. Signs Amended, 10-Year Manufacturing and Testing Agreement with LyoGenesis Holdings Aug 17